Nebivolol
- Product NDC
- 70756-025
- 11-digit product format
- 707560025
- Labeler code
- 70756
- Product ID
- 70756-025_2ffb359c-7e4b-44ef-a0c7-451ac966f6b6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nebivolol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Lifestar Pharma LLC
- Application
- ANDA216172
- Marketing category
- ANDA
- Marketing start
- 2022-11-14
- Substance
- NEBIVOLOL HYDROCHLORIDE
- Active strength
- 2.5 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Nebivolol
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NEBIVOLOL HYDROCHLORIDE | 2.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | JGS34J7L9I |
| Rxcui | 387013, 751612, 751618, 827073 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70756-025-30 | Nebivolol | 30 in 1 BOTTLE | TABLET | 30 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70756-025 | NEBIVOLOL TABLET [LIFESTAR PHARMA LLC] | 5 | Current NDC, Legacy NDC, 1 package rows | 20230717_2639abce-a5ca-4b7f-99d7-026ab3233aaa.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70756-025-30 | 70756002530 | 30 TABLET in 1 BOTTLE (70756-025-30) | 30 tablet | 2022-11-14 | 0000-00-00 | No | No | Current |